Screening for 6- phosphogluconate dehydrogenase abnormalities in the blood of dermatological patients.
The results of screening for 6-phosphogluconate dehydrogenase abnormalities in the blood of dermatological patients are reported. No differences were found between controls, psoriatics, psoriatics receiving methotrexate and a group of mixed patients. The results are discussed in relation to the effects of methotrexate on glucose-6-phosphate dehydrogenase.
D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D010734:Phosphogluconate Dehydrogenase / Q000097:blood*; D011565:Psoriasis / Q000188:drug therapy / Q000201:enzymology; D012871:Skin Diseases / Q000201:enzymology*
D010734:Phosphogluconate Dehydrogenase; D008727:Methotrexate